» Articles » PMID: 36843107

Incidence and Prevalence of Epilepsy in Japan: A Retrospective Analysis of Insurance Claims Data of 9,864,278 Insured Persons

Overview
Journal J Epidemiol
Specialty Public Health
Date 2023 Feb 27
PMID 36843107
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The burden of epilepsy is thought to be high but is difficult to measure. Very few studies in Japan have attempted to estimate prevalence and incidence rates of epilepsy in Japan.

Methods: This retrospective cohort study used commercially collected nationwide insurance claims data from a cohort of 10 million persons between 2012 and 2019 among those aged 0 to 74 years. Using the claims data, cases were identified, and incidence and prevalence rates were estimated.

Results: A total of 9,864,278 persons were included. The average age was 34.5 (standard deviation, 18.5) years. A total of 77,312 persons were diagnosed with epilepsy over the 8-year observation period, with a prevalence rate of 6.0 per 1,000 persons with almost no difference by gender. The highest rates were seen among those aged 70-74 years; prevalence rates tended to rise with calendar year (5.4/1,000 in 2012 and 6.0/1,000 in 2019). The incidence rate of epilepsy was 72.1 per 100,000 person-years with slightly higher rates seen among females. Incidence rates were highest at ages less than 12 months (199.8/100,000 person-years), followed by the eldest age group (70-74 years, 179.4/100,000 person-years).

Conclusion: Understanding the magnitude of disease burden is the basis of determining health policies. In this study, the prevalence and incidence of epilepsy in Japan was shown based on the analysis results of a large-scale general population insurance claims data covering all over Japan.

Citing Articles

Development and validation of the Japanese version of the Public Attitudes Toward Epilepsy (PATE-J) Scale.

Hatakeda J, Shimazaki H, Kuramochi I, Iwayama T, Kobayashi S, Matsuki H PCN Rep. 2024; 3(4):e70045.

PMID: 39711578 PMC: 11659727. DOI: 10.1002/pcn5.70045.

References
1.
Sen A, Jette N, Husain M, Sander J . Epilepsy in older people. Lancet. 2020; 395(10225):735-748. DOI: 10.1016/S0140-6736(19)33064-8. View

2.
Olafsson E, Hauser W . Prevalence of epilepsy in rural Iceland: a population-based study. Epilepsia. 1999; 40(11):1529-34. DOI: 10.1111/j.1528-1157.1999.tb02036.x. View

3.
. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(4):357-375. PMC: 6416168. DOI: 10.1016/S1474-4422(18)30454-X. View

4.
Fiest K, Sauro K, Wiebe S, Patten S, Kwon C, Dykeman J . Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2016; 88(3):296-303. PMC: 5272794. DOI: 10.1212/WNL.0000000000003509. View

5.
Tanaka A, Hata J, Akamatsu N, Mukai N, Hirakawa Y, Yoshida D . Prevalence of adult epilepsy in a general Japanese population: The Hisayama study. Epilepsia Open. 2019; 4(1):182-186. PMC: 6398097. DOI: 10.1002/epi4.12295. View